MENU
CALT
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Calliditas Therapeutics AB (CALT) Ownership - Who owns Calliditas Therapeutics AB?

Profile

Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.1B
P/E Ratio
N/A
Total Cash
797.28M
Projected Growth
N/A
Total Debt
1.01B
Revenue
1.6B
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash/Share
29.51
Total Debt/Equity
N/A
Revenue/Share
5.89 USD as % of share price

Fundamentals

CALT
Capitalization
1.1B
P/E Ratio
N/A
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash
797M
Total Cash/Share
29.51
Total Debt
1.01B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.89%
Revenue
1.6B
ROE
N/A
Book Value
107M
P/B Ratio
102.04
Cash Flow
N/A
Earnings
-17.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
2.69
Current Revenue Per Employee
2521531.50
Dividends Per Share - Security
N/A
EBITDA
-363.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.45
Revenue To Assets
-27.80
Shares Held By Institutions
32.8M
Shares Outstanding - Current
27M
Total Liabilities
1.64B
Total Volume MTD
N/A
Value
-1
Gain YTD
55.376
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for patients with niche indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se